290 related articles for article (PubMed ID: 22901709)
1. Postpartum hemorrhage in the developed world: whither misoprostol?
Gibbins KJ; Albright CM; Rouse DJ
Am J Obstet Gynecol; 2013 Mar; 208(3):181-3. PubMed ID: 22901709
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
[TBL] [Abstract][Full Text] [Related]
3. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.
Vallera C; Choi LO; Cha CM; Hong RW
Anesthesiol Clin; 2017 Jun; 35(2):207-219. PubMed ID: 28526143
[TBL] [Abstract][Full Text] [Related]
4. [Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin].
Triopon G; Goron A; Agenor J; Aya GA; Chaillou AL; Begler-Fonnier J; Bousquet PJ; Mares P
Gynecol Obstet Fertil; 2010 Dec; 38(12):729-34. PubMed ID: 21111653
[TBL] [Abstract][Full Text] [Related]
5. Is Misoprostol Equivalent to Oxytocin for Postpartum Hemorrhage?
Chireau MV
Issues Law Med; 2015; 30(2):217-25. PubMed ID: 26710381
[No Abstract] [Full Text] [Related]
6. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
7. [Carbetocin and oxytocin: Prevention of postpartum hemorrhage in patients with risk factors for uterine atony].
Carrillo-Gaucín S; Torres-Gómez LG
Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 3():S284-S290. PubMed ID: 27855051
[TBL] [Abstract][Full Text] [Related]
8. Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach.
Koch DM; Rattmann YD
Einstein (Sao Paulo); 2020; 18():eAO5029. PubMed ID: 31721897
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol for the prevention and treatment of postpartum hemorrhage.
Sheldon WR; Blum J; Durocher J; Winikoff B
Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
[TBL] [Abstract][Full Text] [Related]
10. Uterine atony.
Miller HE; Ansari JR
Curr Opin Obstet Gynecol; 2022 Apr; 34(2):82-89. PubMed ID: 35102109
[TBL] [Abstract][Full Text] [Related]
11. Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents.
Jaffer D; Singh PM; Aslam A; Cahill AG; Palanisamy A; Monks DT
Am J Obstet Gynecol; 2022 Mar; 226(3):347-365. PubMed ID: 34534498
[TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage.
Olufowobi O; Afnan M; Sorinola O; Papaioannou S; Sharif K
Acta Obstet Gynecol Scand; 2002 Oct; 81(10):993; author reply 994. PubMed ID: 12366496
[No Abstract] [Full Text] [Related]
13. [Misoprostol: off-label use in the treatment of post-partum hemorrhage].
Garrigue A; Pierre F
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):179-89. PubMed ID: 24457021
[TBL] [Abstract][Full Text] [Related]
14. [Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study].
Shojai R; Piéchon L; d'Ercole C; Boubli L; Pontiès JE
J Gynecol Obstet Biol Reprod (Paris); 2001 Oct; 30(6):572-5. PubMed ID: 11883024
[TBL] [Abstract][Full Text] [Related]
15. Misoprostol in the prevention of postpartum hemorrhage.
Mategrano VA; Gabay MP
Ann Pharmacother; 2001 Dec; 35(12):1648-52. PubMed ID: 11793636
[TBL] [Abstract][Full Text] [Related]
16. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
[TBL] [Abstract][Full Text] [Related]
17. Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone.
Jones AJ; Federspiel JJ; Eke AC
Am J Obstet Gynecol MFM; 2023 Feb; 5(2S):100731. PubMed ID: 36028160
[TBL] [Abstract][Full Text] [Related]
18. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].
Fekih M; Jnifene A; Fathallah K; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Khairi H
J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour.
Cook CM; Spurrett B; Murray H
Aust N Z J Obstet Gynaecol; 1999 Nov; 39(4):414-9. PubMed ID: 10687755
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
Haque N; Bilkis L; Haque N; Bari MS; Haque S
Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
